Fibrinogen Milano IV (A alpha 16 Arg-->His): characterization of its abnormal interaction with human alpha-thrombin.
作者信息
De Cristofaro R, Furlan M, Landolfi R
出版信息
Biochem J. 1994 Sep 1;302 ( Pt 2)(Pt 2):623-4.
Abstract
摘要
相似文献
1
Fibrinogen Milano IV (A alpha 16 Arg-->His): characterization of its abnormal interaction with human alpha-thrombin.米兰纤维蛋白原IV（Aα16位精氨酸突变为组氨酸）：其与人类α-凝血酶异常相互作用的特征
Biochem J. 1994 Sep 1;302 ( Pt 2)(Pt 2):623-4.
2
3
4
5
Fibrinogen New Britain: characterization of an A alpha Arg 16-->His variant human fibrinogen.
Blood Coagul Fibrinolysis. 1994 Apr;5(2):233-8.
6
Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.
Eur J Haematol. 1990 Jul;45(1):26-30. doi: 10.1111/j.1600-0609.1990.tb00410.x.
7
Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
Haemostasis. 1992;22(1):7-11. doi: 10.1159/000216285.
8
Fibrinogen Stony Brook II: partial characterization of a heterozygously transmitted peptide A anomaly.纤维蛋白原斯托尼布鲁克II：杂合传递的肽A异常的部分特征
Blood Coagul Fibrinolysis. 1990 Oct;1(4-5):567-70.
9
Fibrinogen Osaka IV: a congenital dysfibrinogenemia found in a patient originally reported in relation to surgery, now defined to have an A alpha arginine-16 to histidine substitution.大阪纤维蛋白原IV型：一种先天性异常纤维蛋白原血症，最初在一名与手术相关的患者中发现，现确定存在α-A链精氨酸16被组氨酸替代的情况。
Surg Today. 1993;23(1):45-50. doi: 10.1007/BF00308999.
10
Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution.
Haemostasis. 1990;20(1):1-7. doi: 10.1159/000216098.
本文引用的文献
1
The linkage between binding of the C-terminal domain of hirudin and amidase activity in human alpha-thrombin.水蛭素C末端结构域的结合与人α-凝血酶中酰胺酶活性之间的联系。
Biochem J. 1993 Jan 15;289 ( Pt 2)(Pt 2):475-80. doi: 10.1042/bj2890475.
2
Effect of temperature on the association step in thrombin-fibrinogen interaction.温度对凝血酶-纤维蛋白原相互作用中结合步骤的影响。
Biochem J. 1993 Sep 1;294 ( Pt 2)(Pt 2):563-7. doi: 10.1042/bj2940563.
3
Effects of protons on the thrombin-fibrinogen interaction.质子对凝血酶-纤维蛋白原相互作用的影响。
Eur J Biochem. 1994 Feb 1;219(3):1013-21. doi: 10.1111/j.1432-1033.1994.tb18584.x.
4
5
Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin.凝血酶催化人纤维蛋白原转化为纤维蛋白的稳态动力学参数。
J Biol Chem. 1983 Aug 10;258(15):9276-82.
6
Multiple specificity of thrombin for synthetic substrates.凝血酶对合成底物的多重特异性。
Nature. 1967 Jan 28;213(5074):405-6. doi: 10.1038/213405a0.
7
Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitution.凝血酶诱导具有Aα精氨酸-16至组氨酸替代的纤维蛋白原变体（悉尼I型纤维蛋白原）释放纤维蛋白肽。
Eur J Biochem. 1985 Mar 15;147(3):593-600. doi: 10.1111/j.0014-2956.1985.00593.x.
8
Structural and functional properties of human alpha-thrombin, phosphopyridoxylated alpha-thrombin, and gamma T-thrombin. Identification of lysyl residues in alpha-thrombin that are critical for heparin and fibrin(ogen) interactions.人α-凝血酶、磷酸吡哆醛化α-凝血酶和γT-凝血酶的结构与功能特性。确定α-凝血酶中对肝素和纤维蛋白（原）相互作用至关重要的赖氨酰残基。
J Biol Chem. 1989 Nov 5;264(31):18419-25.
9
The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen.水蛭素的羧基末端结构域。一种针对外结合位点的α-凝血酶对纤维蛋白原作用的竞争性抑制剂。
J Biol Chem. 1990 Aug 15;265(23):13484-9.
10
Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.α-凝血酶的水蛭素和水蛭素-1复合物的结构
J Mol Biol. 1991 Oct 20;221(4):1379-93.
Zotero 插件